ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Klotho Neurosciences Inc

Klotho Neurosciences Inc (KLTO)

0.461
-0.0031
(-0.67%)
Closed December 26 3:00PM
0.4649
0.0039
( 0.85% )
Pre Market: 5:25AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.4649
Bid
0.4514
Ask
0.51
Volume
350
0.00 Day's Range 0.00
0.26 52 Week Range 0.99
Previous Close
0.461
Open
-
Last Trade
1
@
0.47
Last Trade Time
05:59:04
Average Volume (3m)
553,982
Financial Volume
-
VWAP
-

KLTO Latest News

Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences’ Scientific Advisory Board

NEW YORK, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Klotho Neurosciences, Inc. (NASDAQ: KLTO), a specialty biotechnology company focused on developing cell and gene therapies for amyotrophic lateral...

Former Merck USA President Joins Klotho Neurosciences’ Board of Directors

NEW YORK, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Klotho Neurosciences, Inc. (NASDAQ: KLTO), a U.S.-based biotechnology company pioneering cell and gene therapies for neurodegenerative and age-related...

Dr. Makoto Kuro-o, Pioneer of the Klotho Anti-Aging Gene, Joins Klotho Neurosciences, Inc. as Scientific Advisor

NEW YORK, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Klotho Neurosciences, Inc. (NASDAQ: KLTO), a leading biotechnology company focused on developing cell and gene therapies for aging and age-related...

Co-Founder of Shire Pharmaceuticals Appointed as Chief Operating Officer of Klotho Neurosciences

NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Klotho Neurosciences, Inc. (NASDAQ: KLTO), a U.S.-based biotechnology company pioneering cell and gene therapies for aging and age-related diseases...

Dr. Robert Langer, Co-Founder of Moderna, Joins Scientific Advisory Board of Klotho Neurosciences, Inc. (KLTO)

NEW YORK, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Klotho Neurosciences, Inc. (NASDAQ: KLTO), a cutting-edge biotechnology company focused on developing innovative therapies for neurodegenerative...

Dr. Robert Langer, Co-Founder of Moderna, Joins Scientific Advisory Board of Klotho Neurosciences, Inc. (KLTO)

NEW YORK, Sept. 29, 2024 (GLOBE NEWSWIRE) -- Klotho Neurosciences, Inc. (NASDAQ: KLTO), a cutting-edge biotechnology company focused on developing innovative therapies for neurodegenerative...

ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc.

NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- The Board of ANEW MEDICAL, INC. (NASDAQ: WENA), today announced a name and ticker symbol change to Klotho Neurosciences, Inc. (NASDAQ: KLTO), and has...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.04199.905437352250.4230.4990.421035390.4462043CS
40.124936.73529411760.340.690.325510412700.39785924CS
12-0.0601-11.44761904760.5250.880.265539820.4555993CS
26-0.338-42.09739693610.80290.990.264681920.46555668CS
52-0.338-42.09739693610.80290.990.264681920.46555668CS
156-0.338-42.09739693610.80290.990.264681920.46555668CS
260-0.338-42.09739693610.80290.990.264681920.46555668CS

KLTO - Frequently Asked Questions (FAQ)

What is the current Klotho Neurosciences share price?
The current share price of Klotho Neurosciences is US$ 0.4649
What is the 1 year trading range for Klotho Neurosciences share price?
Klotho Neurosciences has traded in the range of US$ 0.26 to US$ 0.99 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
INTZIntrusion Inc
US$ 2.29
(408.89%)
44.28M
WIMIWiMi Hologram Cloud Inc
US$ 2.39
(85.27%)
9.12M
IDAIT Stamp Inc
US$ 0.8593
(59.13%)
19.64M
RVSNRail Vision Ltd
US$ 1.19
(53.83%)
15.94M
EVAXEvaxion Biotech AS
US$ 1.275
(50.71%)
2.59M
LATGChenghe Acquisition I Company
US$ 9.50
(-23.23%)
167
CUBLionheart Holdings
US$ 8.01
(-20.61%)
1
KALVKalVista Pharmaceuticals Inc
US$ 7.01
(-20.61%)
1
QRHCQuest Resource Holding Corporation
US$ 5.00
(-19.35%)
425
GOCOGoHealth Inc
US$ 11.01
(-17.71%)
7
INTZIntrusion Inc
US$ 2.29
(408.89%)
44.28M
IDAIT Stamp Inc
US$ 0.8593
(59.13%)
19.64M
QSIQuantum Si Inc
US$ 3.23
(50.23%)
17.44M
RVSNRail Vision Ltd
US$ 1.19
(53.83%)
15.94M
XTIAXTI Aerospace Inc
US$ 0.043
(7.50%)
15.21M

KLTO Discussion

View Posts
Hugie Hugie 4 days ago
It shows for a worthless company.
👍️0
zerohedge zerohedge 2 weeks ago
Seems they’ve paid someone in stock issuing a $1.2mm note OID -20% and gave the same investor 2,000,000 shares of stock to buy the note. The note is convertible at $0.25 per share. In other words, they sold shares for $0.12. Who is running the BOD?
👍️0
TrendTrade2016 TrendTrade2016 4 weeks ago
klto monster
👍️0
TrendTrade2016 TrendTrade2016 4 weeks ago
klto running
👍️0
TrendTrade2016 TrendTrade2016 4 weeks ago
klto running
👍️0
Hugie Hugie 1 month ago
Leas was a Scam and wena,Klto the same.Scam.
👍️0
TheOTCstocksGuy TheOTCstocksGuy 2 months ago
Get this trash delisted already!!! It's been trading under $1 for well over 10 days!!! Get it together SEC and do your job! 
👍️0
Laster Laster 2 months ago
Friday was interesting. Will it continue to show volume today?
Break $0,80 and I think we hit $1.00 this week.
Hmmmmm….
👍️0
Laster Laster 2 months ago
Year chart might be showing a nice flag formation.
I might grab some today if we get to $0,65.
I will buy more at $0.70.
Enjoy
👍️0
Laster Laster 2 months ago
Pump and dump?
Lull before the storm?
Watching but not excited about the trading.
If it moves back to $0.70 then I might buy a few.
👍️0
Laster Laster 2 months ago
Cofounder of Shire and cofounder of Moderna involved… why?
Looks like a small cap biotech with some interesting trading today.
Closely watching this play.
👍️0
BeeHaus2 BeeHaus2 3 months ago
Can we change name of this Board to KLTO? or merge them
👍️0
BeeHaus2 BeeHaus2 3 months ago
The Board of ANEW MEDICAL, INC. (NASDAQ: WENA), today announced a name and ticker symbol change to Klotho Neurosciences, Inc. (NASDAQ: KLTO), and has launched a new website, www.klothoneuro.com. The name and ticker change will have no impact on current shareholders, and there is no action required on their part.
The new name embodies the Company's commitment to strategically direct its core investments of time and financial resources toward the multibillion-dollar market opportunities for the company’s patented Klotho gene technology assets in the neurosciences sector. Through its exclusive worldwide license, the company’s patent protected secreted form of the Klotho gene, s-KL, provides Klotho Neurosciences with the opportunity to invest its strategic resources into two distinct major market segments.
👍️0
TheOTCstocksGuy TheOTCstocksGuy 4 months ago
More like .75 and then lower by the day! Trash!!
👍️0
TheOTCstocksGuy TheOTCstocksGuy 4 months ago
Love watching this POS FAIL!! Get this delisted and lock up the Doc!!!
👍️0
Monksdream Monksdream 4 months ago
WENA new 52 week low
👍️0
tw0122 tw0122 4 months ago
Pulling a nice Oscar Meyer WENA move up .. 06:05 AM EDT, 08/21/2024 (MT Newswires) -- Anew Medical (WENA) said Wednesday it signed an exclusive worldwide license agreement with Transfertech Sherbrooke for Nanoject.

Financial terms were not disclosed.

Nanoject is a needle-free, freeze-dried nanopowder autoinjector for medicines and vaccines.

Shares of the company jumped over 48% in recent premarket activity Wednesday.
👍️0
BeeHaus2 BeeHaus2 4 months ago
yup. I'll buy this turd when it's at a penny or less. Losers.
👍️0
Sauna Sauna 4 months ago
Piece of Shit Scummer stinky Doc 💩💩
👍️0
glenn1919 glenn1919 4 months ago
WENA.......................https://stockcharts.com/h-sc/ui?s=WENA&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 5 months ago
WENA........................https://stockcharts.com/h-sc/ui?s=WENAp=W&b=5&g=0&id=p86431144783
👍️0
ZimZum ZimZum 5 months ago
Loaded ready to go!!!
👍️0
trader_ron trader_ron 5 months ago
Liftoff $1.75pps coming
👍️0
peterus peterus 5 months ago
yup could blow up
👍️0
81vette 81vette 5 months ago
ZERO BORROW on this low floater,could get interesting
👍️0
Monksdream Monksdream 5 months ago
WENA under $2
👍️0
Sauna Sauna 5 months ago
Doctor Stink 💩
👍️0
gail gail 5 months ago
hopped back in today.
👍️0
Dantheoneman Dantheoneman 6 months ago
Weeeeeee
👍️0
Dantheoneman Dantheoneman 6 months ago
Just picked up Few. This is Priming. I’ll buy more once Break Happens
👍️0
Dantheoneman Dantheoneman 6 months ago
This one Almost Ready! Looking for a $1.80 Break and I’m in!
👍️0
Dantheoneman Dantheoneman 6 months ago
Got a Runner.
👍️0
tw0122 tw0122 6 months ago
W YORK, July 09, 2024 (GLOBE NEWSWIRE) -- ANEW MEDICAL, INC. (NASDAQ: WENA) (“ANEW”), a biopharmaceutical company specializing in the advancement of novel disease-modifying therapies for neurological and age-related disorders, announces plans to advance its recently patented Klotho gene therapy program for neurodegenerative disorders.

ANEW has compelling initial data suggesting that maintaining elevated levels of Klotho in the body significantly contributes to longer, healthier lifespans. Conversely, the data reveals that individuals with depleted or lower-than-normal levels of Klotho are more susceptible to neurodegenerative disorders such as ALS, Alzheimer’s, and Parkinson’s Disease. ANEW will also investigate other age-related disorders associated with depleted Klotho levels, such as memory loss, osteoporosis, sarcopenia (muscle wasting), diabetes mellitus, and certain cardiovascular conditions.

Dr. Joseph Sinkule, CEO and Founder of ANEW MEDICAL, commented: “Administering a medication based on the Klotho isoform of interest, secreted Klotho (s-KL), may contribute to longer, healthier lives. Research by our strategic partner, the Okinawa Research Center for Longevity Science (ORCLS) in Japan, suggests that the Klotho gene is a key factor in age-related longevity. Klotho emerged as one of the two most significant genes from their studies, and we look forward to continuing our research with ORCLS as we advance ANEW’s clinical development programs for Neurodegenerative Disorders.”

ANEW has development plans to advance its program in three distinct areas:

FDA Clinical Trials: The development of therapeutics to treat neurodegenerative diseases and age-related disorders involves using an adenovirus (AAV) vector to deliver the secreted Klotho gene DNA sequence to neurons in the central nervous system (CNS). This approach aims to correct deficiencies in the levels of s-KL.
$2.18 + 50% Klotho Diagnostics: The development and commercialization of a diagnostic that will enable healthcare providers to accurately quantify levels of Klotho gene and protein isoforms in blood samples. This tool will also provide ANEW with the necessary diagnostic to screen patients for its clinical trials.
Age-Related Disorders: ANEW plans to develop exploratory approaches to promote longevity in healthy populations using gene or cell-based Klotho therapies, as well as other genes of interest that are directly related to longevity.
Dr. Shalom Hirshman, M.D., Chief Medical Advisor and Board member, stated: “ANEW is in a strong position to significantly influence the treatment of ALS, Alzheimer’s, and other neurodegenerative disorders. With our patent-protected gene therapy platform technology, we have the potential to improve health and extend life expectancy.”
👍️0
Uncleval Uncleval 6 months ago
$LEAS $RWOD $WENA Criminality is criminality, plain and simple. This company was built on the backs of innocent investors like myself and many others who had their investments in the sister company, $LEAS, fraudulently wiped out by a rogue Doctor, Joseph Sinkule, and his accomplices. They stole 99% of our hard-earned resources, leaving us with almost nothing. But they underestimated us - We wont just cry and walk away. I personally will follow this stock to its ultimate demise, its grave. Please Join the class action lawsuit folks…
👍️0
Uncleval Uncleval 6 months ago
Warning: $WENA, $LEAS, and $RWOD are complete scams! They have defrauded innocent investors and I urge you to exercise extreme caution. Do not put your money into $WENA or related companies being managed by especially Dr. Joseph Sinkule aka Dr. Sink-Hole. These scammers will stop at nothing to deceive and exploit vulnerable investors. Beware of fraud!!!
👍️0
glenn1919 glenn1919 6 months ago
WENA.........................https://stockcharts.com/h-sc/ui?s=WENA&p=W&b=5&g=0&id=p86431144783
👍️0
TrendTrade2016 TrendTrade2016 6 months ago
WENA COVER BOTTOM PLAY
👍️0
DEMDOTS DEMDOTS 6 months ago
wena is rising :o)
👍️0
BeeHaus2 BeeHaus2 6 months ago
Still just holding my limp WENA...
👍️0
gail gail 6 months ago
grabbed some.
👍️0
trader59 trader59 6 months ago
I guess the folks who bought that stock right before the merger hired the computer wash traders to help them dump it in.

Don't get trapped... this isn't real.
👍️0
DEMDOTS DEMDOTS 6 months ago
thought there was only 5000000 shares hmmm :o)
👍️0
tbonaces80 tbonaces80 6 months ago
Buying here. Slow walk down
👍️0
trader_ron trader_ron 6 months ago
and I’m out, taking profits is what’s been my secret, and kept me in the game. GL
👍️0
Propain Propain 6 months ago
I bought some shares about 30 minutes ago. Thats what caused the down turn. Sorry. I kill stocks every time I buy.
👍️0
Invest-in-America Invest-in-America 6 months ago
WENAW (Warrants): That's what I grabbed --- hope we all get a big, fat, 10-bagger today!!
👍️0
zerohedge zerohedge 6 months ago
As mentioned yesterday - anyone short is going to get squeezed to death -
👍️0
BeeHaus2 BeeHaus2 6 months ago
...granted and issued a patent in Europe, EP3377091B1, for the use of ANEW’s secreted Klotho gene sequence and gene delivery systems to be used in the treatment of diminished cognition, memory loss, dementia and other neurodegenerative diseases.
👍️0
Welsh_Dragon Welsh_Dragon 6 months ago
Nice news. No stocktwits or yahoo board.
👍️0
BeeHaus2 BeeHaus2 6 months ago
...and now we are left holding our WENAs.
👍️0